Entera Bio Announces First Quarter 2025 Financial Results and Business Updates JERUSALEM, May 09, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of…
Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader…
Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates Entera Bio (ENTX) delivered earnings and revenue surprises of -60% and 5%, respectively, for the quarter ended September 2024. Do…
Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates JERUSALEM , Aug. 09, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a…
Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024 JERUSALEM, May 13, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader…
Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates JERUSALEM, May 10, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader…
Heres Why You Should Invest in Entera Bio (ENTX) Stock Now Here, we discuss some reasons why buying Entera Bio (ENTX) stock now may turn out to be a prudent move.…
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2 OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.…
Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader…